Levocarnitine for reducing anemia medication in dialysis patients
Treatments studied
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a supplement called levocarnitine can help reduce the dose of an anemia medication you may need. It might help improve anemia control in people on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old.
- You have been on dialysis (hemodialysis) three times a week for at least 6 months.
- You have anemia caused by kidney disease.
- You are not currently taking carnitine supplements and have never taken levocarnitine before.
- You have not had a blood transfusion in the last 6 months.
- You are not taking immunosuppressive drugs, steroids, or antibiotics, and you do not have acute inflammation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called spironolactone can help children on hemodialysis who still have anemia despite usual treatment. It aims to see if this drug improves red blood cell production better than standard care alone.
This trial tests whether taking carnitine supplements by mouth can help people who have both heart failure and early-to-moderate kidney problems. It's an early-phase study to see if the supplement is safe and works for this group.
This study tests whether adding L-carnitine (a naturally occurring compound) to standard care helps people with serious liver disease who are in the intensive care unit. L-carnitine may help the body use energy better and reduce complications from liver failure.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This study tests an experimental medicine for anemia in people with kidney disease who are on dialysis. It aims to see if it can help raise blood counts safely compared to standard treatments.
This study looks at a possible nutritional supplement (valine) to help people with advanced chronic kidney disease who also have muscle weakness (sarcopenia). It will test whether the supplement can improve muscle strength and function.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.